Carsten Hagemann

ORCID

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 14

Top Venues

Cancers

Pharmaceutics

International journal of molecular sciences

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Jonas Feldheim, Almuth F Kessler, Julia J Feldheim, Dominik Schmitt, Christoph Oster, Lazaros Lazaridis, Martin Glas, Ralf-Ingo Ernestus, Camelia M Monoranu, Mario Löhr, Carsten Hagemann
BRMS1 in Gliomas-An Expression Analysis. Cancers 15 (11) (2023)
Ellaine Salvador, Theresa Köppl, Julia Hörmann, Sebastian Schönhärl, Polina Bugaeva, Almuth F Kessler, Malgorzata Burek, Ralf-Ingo Ernestus, Mario Löhr, Carsten Hagemann
Tumor Treating Fields (TTFields) Induce Cell Junction Alterations in a Human 3D In Vitro Model of the Blood-Brain Barrier. Pharmaceutics 15 (1) (2023)
Jonas Alexander Feldheim, Teresa Schmidt, Christoph Oster, Julia Feldheim, Martin Stuschke, Walter Stummer, Oliver Grauer, Björn Scheffler, Carsten Hagemann, Ulrich Sure, Christoph Kleinschnitz, Lazaros Lazaridis, Sied Kebir, Martin Glas
Telemedicine in Neuro-Oncology-An Evaluation of Remote Consultations during the COVID-19 Pandemic. Cancers 15 (16) (2023)
Maria Breun, Katharina Flock, Jonas Alexander Feldheim, Anja Nattmann, Camelia M Monoranu, Pia Herrmann, Ralf-Ingo Ernestus, Mario Löhr, Carsten Hagemann, Ulrike Stein
Metastasis Associated in Colorectal Cancer 1 (MACC1) mRNA Expression Is Enhanced in Sporadic Vestibular Schwannoma and Correlates to Deafness. Cancers 15 (16) (2023)
Ignace Vergote, Teresa Macarulla, Fred R Hirsch, Carsten Hagemann, David Scott Miller
Tumor Treating Fields (TTFields) Therapy Concomitant with Taxanes for Cancer Treatment. Cancers 15 (3) (2023)
Ellaine Salvador, Theresa Köppl, Julia Hörmann, Sebastian Schönhärl, Polina Bugaeva, Almuth F Kessler, Malgorzata Burek, Ralf-Ingo Ernestus, Mario Löhr, Carsten Hagemann
Tumor Treating Fields (TTFields) Induce Cell Junction Alterations in a Human 3D In Vitro Model of the Blood-Brain Barrier. Pharmaceutics 15 (1) (2023)
Ellaine Salvador, Theresa Köppl, Julia Hörmann, Sebastian Schönhärl, Polina Bugaeva, Almuth F Kessler, Malgorzata Burek, Ralf-Ingo Ernestus, Mario Löhr, Carsten Hagemann
Tumor Treating Fields (TTFields) Induce Cell Junction Alterations in a Human 3D In Vitro Model of the Blood-Brain Barrier. Pharmaceutics 15 (1) (2023)
Ignace Vergote, Teresa Macarulla, Fred R Hirsch, Carsten Hagemann, David Scott Miller
Tumor Treating Fields (TTFields) Therapy Concomitant with Taxanes for Cancer Treatment. Cancers 15 (3) (2023)
Vera Nickl, Juliana Eck, Nicolas Goedert, Julian Hübner, Thomas Nerreter, Carsten Hagemann, Ralf-Ingo Ernestus, Tim Schulz, Robert Carl Nickl, Almuth Friederike Keßler, Mario Löhr, Andreas Rosenwald, Maria Breun, Camelia Maria Monoranu
Characterization and Optimization of the Tumor Microenvironment in Patient-Derived Organotypic Slices and Organoid Models of Glioblastoma. Cancers 15 (10) (2023)
Jonas Feldheim, Almuth F Kessler, Julia J Feldheim, Ellina Schulz, David Wend, Lazaros Lazaridis, Christoph Kleinschnitz, Martin Glas, Ralf-Ingo Ernestus, Sebastian Brandner, Camelia M Monoranu, Mario Löhr, Carsten Hagemann
Effects of Long-Term Temozolomide Treatment on Glioblastoma and Astrocytoma WHO Grade 4 Stem-like Cells. International journal of molecular sciences 23 (9) (2022)
Vera Nickl, Ellina Schulz, Ellaine Salvador, Laureen Trautmann, Leopold Diener, Almuth F Kessler, Camelia M Monoranu, Faramarz Dehghani, Ralf-Ingo Ernestus, Mario Löhr, Carsten Hagemann
Glioblastoma-Derived Three-Dimensional Ex Vivo Models to Evaluate Effects and Efficacy of Tumor Treating Fields (TTFields). Cancers 14 (21) (2022)
Justin C Moser, Ellaine Salvador, Karina Deniz, Kenneth Swanson, Jack Adam Tuszynski, Kristen W Carlson, Narasimha Kumar Karanam, Chirag B Patel, Michael D Story, Emil Lou, Carsten Hagemann
The Mechanisms of Action of Tumor Treating Fields. Cancer research 82 (20) (2022)
Jonas Alexander Feldheim, David Wend, Mara J Lauer, Camelia M Monoranu, Martin Glas, Christoph Kleinschnitz, Ralf-Ingo Ernestus, Barbara M Braunger, Patrick Meybohm, Carsten Hagemann, Malgorzata Burek
Protocadherin Gamma C3 (PCDHGC3) Is Strongly Expressed in Glioblastoma and Its High Expression Is Associated with Longer Progression-Free Survival of Patients. International journal of molecular sciences 23 (15) (2022)
Ellaine Salvador, Almuth F Kessler, Dominik Domröse, Julia Hörmann, Clara Schaeffer, Aiste Giniunaite, Malgorzata Burek, Catherine Tempel-Brami, Tali Voloshin, Alexandra Volodin, Adel Zeidan, Moshe Giladi, Ralf-Ingo Ernestus, Mario Löhr, Carola Yvette Förster, Carsten Hagemann
Tumor Treating Fields (TTFields) Reversibly Permeabilize the Blood-Brain Barrier In Vitro and In Vivo. Biomolecules 12 (10) (2022)

Carsten Hagemann.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Carsten Hagemann